Traws Pharma, Inc.
TRAW
21 insider filings · Latest: Jul 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | Apr 29 1:41 AM | ORBIMED ADVISORS LLC10% Owner | Purchase | 597,729 | $1.67 | $998.2K | 1,203,250(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Jul 16 4:39 PM | Charles David PauzaChief Science Officer Virology | Grant/Award | 97,000 | $0.68 | 97,000(D) | View → |
| Jul 9, 2026 | Jul 16 1:32 AM | Werner CautreelsDirector | Grant/Award | 14,150 | $0.68 | 14,150(D) | View → |
| Jul 9, 2026 | Jul 15 8:32 PM | Nikolay SavchukDirector, Chief Operating Officer | Grant/Award | 93,000 | $0.68 | 93,000(D) | View → |
| Jul 9, 2026 | Jul 15 1:57 AM | Jack E StoverDirector | Grant/Award | 14,150 | $0.68 | 14,150(D) | View → |
| Jul 9, 2026 | Jul 15 12:26 AM | Iain D. DukesDirector, Chief Executive Officer | Grant/Award | 274,000 | $0.68 | 274,000(D) | View → |
| Jul 9, 2026 | Jul 15 12:23 AM | Robert RedfieldChief Medical Officer | Grant/Award | 84,000 | $0.68 | 84,000(D) | View → |
| Jul 9, 2026 | Jul 15 12:22 AM | Charles Nolan ParkerChief Financial Officer | Grant/Award | 90,000 | $0.68 | 90,000(D) | View → |
| Jul 9, 2026 | Jul 15 12:22 AM | Mary Teresa ShoemakerDirector | Grant/Award | 14,150 | $0.68 | 14,150(D) | View → |
| Jul 9, 2026 | Jul 15 12:21 AM | Trafford ClarkeDirector | Grant/Award | 14,150 | $0.68 | 14,150(D) | View → |
| Jul 9, 2026 | Jul 15 12:19 AM | John Harold LeamanDirector | Grant/Award | 14,150 | $0.68 | 14,150(D) | View → |
| Apr 16, 2026 | Apr 29 1:41 AM | ORBIMED ADVISORS LLC10% Owner | Purchase | 2,988,645 | $1.67 | 1,793,187(I) | View → |
| Mar 8, 2026 | Apr 8 6:47 PM | Charles Nolan ParkerChief Financial Officer | Grant/Award | 104,544 | $1.60 | 104,544(D) | View → |
| Dec 12, 2025 | Apr 8 6:47 PM | Charles Nolan ParkerChief Financial Officer | Grant/Award | 61,571 | $2.33 | 61,571(D) | View → |
| Oct 12, 2025 | Apr 8 6:47 PM | Charles Nolan ParkerChief Financial Officer | Grant/Award | 32,406 | $3.01 | 32,406(D) | View → |
| Mar 8, 2026 | Mar 10 11:22 PM | Trafford ClarkeDirector | Grant/Award | 33,435 | $1.60 | 33,435(D) | View → |
| Mar 8, 2026 | Mar 10 11:21 PM | Werner CautreelsDirector | Grant/Award | 31,258 | $1.60 | 31,258(D) | View → |
| Mar 8, 2026 | Mar 10 11:20 PM | John Harold LeamanDirector | Grant/Award | 33,435 | $1.60 | 33,435(D) | View → |
| Mar 8, 2026 | Mar 10 11:19 PM | Iain D. DukesDirector, Chief Executive Officer | Grant/Award | 231,336 | $1.60 | 231,336(D) | View → |
| Mar 8, 2026 | Mar 10 11:18 PM | Charles David PauzaChief Science Officer Virology | Grant/Award | 118,367 | $1.60 | 118,367(D) | View → |
| Mar 8, 2026 | Mar 10 11:17 PM | Nikolay SavchukDirector, Chief Operating Officer | Grant/Award | 96,899 | $1.60 | 96,899(D) | View → |
Page 1 of 2
Next →